Author:
Mylecharane Ewan J.,Ensink Franz Bernhard M.
Publisher
Springer Berlin Heidelberg
Reference92 articles.
1. Bianchine JR, Eade NR (1969) Vasoactive substances and fibrosis. Res Clin Stud Headache 2: 60–85
2. Black JW, Brazenor RM, Gerskowitch VP, Leff P (1983) The problem of insurmountable antagonism in 5-hydroxytryptamine receptor classification. Br J Pharmacol 80: 607P
3. Boer MO den. Heiligers JPC, Saxena PR (1991) Carodd vascular effects of ergotamine and dihydroergotamine in the pig: no exclusive mediation via 5-HT1-like receptors. Br J Pharmacol 104: 183–189
4. Bradley PB, Engel G, Feniuk W, Fozard JR, Humphrey PPA, Middlemiss DN, Mylecharane EJ, Richardson BP, Saxena PR (1986) Proposals for the classification and nomenclature of functional receptors for 5-hydroxytryptamine. Neuropharmacology 25: 563–576
5. Brewerton TD, Murphy DL, Mueller EA, Jimerson DC (1988) Inducdon of mi- grainelike headaches by the serotonin agonist m-chlorphenylpiperazine. Clin Pharmacol Ther 43: 605–609